Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Longevity Venture Partners is an early-stage venture capital fund founded by Stephen Rosedale and Ronald Wilheim. Established to improve the quality and longevity of the older and aging population, the firm is based in Israel and focuses on early-stage opportunities primarily in the Silvertech, Healthcare, and Wellness sectors. The organization seeks to invest in four to six Israeli companies each year, providing not only capital but also industry expertise and access to a network of experts.
The firm emphasizes the importance of enhancing independence among the aging population and explores adjacent sectors that align with its mission. Longevity Venture Partners has built a reputation for its collaborative approach, partnering with corporate investors to create a commercial ecosystem that supports portfolio companies in testing, validating, and refining their value propositions before scaling in the U.S. market.
Longevity Venture Partners invests in early-stage companies within the Silvertech, Healthcare, and Wellness sectors. The firm aims to enhance independence among the aging population and actively seeks opportunities that align with this mission. Their investment strategy includes collaboration with corporate investors, such as CommuniCare, to build a commercial ecosystem that supports portfolio companies.
This ecosystem allows entrepreneurs to leverage resources for commercialization in the U.S. market. The firm primarily targets pre-seed, seed, and seed-plus stages, investing in four to six companies annually. Longevity Venture Partners emphasizes the importance of testing and refining value propositions to facilitate successful scaling in the U.S. market.
Longevity Venture Partners partners with corporate investors to create a commercial ecosystem for its portfolio companies, enabling them to leverage resources for successful commercialization in the U.S. market. While specific portfolio companies are not listed in the provided content, the firm focuses on early-stage investments in the Silvertech, Healthcare, and Wellness sectors.
This approach allows portfolio companies to benefit from industry expertise and access to a network of experts, which is crucial for refining their offerings and achieving market success.
Raissa Hacohen, Managing Partner - Raissa brings extensive experience in venture capital and has a strong background in healthcare investments.
Dr. Jonathan Ringo, M.D., General Partner - Dr. Ringo has a medical background and expertise in healthcare innovation, contributing valuable insights to the investment process.
Stephen L. Rosedale, Chairman of the Board - Stephen has a long history in venture capital and has been instrumental in shaping the firm's strategic direction.
Ronald Wilheim, Esq., Vice-Chairman of the Board - Ronald's legal expertise complements the firm's operations and investment strategies.
To pitch Longevity Venture Partners, founders should visit their website at longevityventurepartners.com. It is advisable to include a clear business model, market analysis, and how the startup aligns with the firm's focus on enhancing the independence of the aging population.
Longevity Venture Partners has been actively seeking early-stage investments in the Silvertech, Healthcare, and Wellness sectors. The firm emphasizes building a commercial ecosystem for its portfolio companies, focusing on testing and refining value propositions to facilitate scaling in the U.S. market.
Recent activities include collaborations with corporate investors like CommuniCare, which enhance the support available to portfolio companies. The firm continues to explore new opportunities that align with its mission of improving the quality of life for the aging population.
What are the investment criteria for Longevity Venture Partners?
Longevity Venture Partners focuses on early-stage companies in the Silvertech, Healthcare, and Wellness sectors. They seek opportunities that enhance the quality of life and independence of the aging population.
How can I pitch to Longevity Venture Partners?
Founders can submit their pitches through the firm's website at longevityventurepartners.com. Specific email addresses for direct contact are not provided.
What makes Longevity Venture Partners different from other VCs?
The firm emphasizes building a commercial ecosystem for its portfolio companies, collaborating with corporate investors to support testing and validation of value propositions before scaling in the U.S. market.
What is the typical check size for investments?
While specific check sizes are not disclosed, Longevity Venture Partners invests in four to six companies annually, primarily at the pre-seed, seed, and seed-plus stages.
What geographic areas does Longevity Venture Partners focus on?
The firm is based in Israel but targets commercialization opportunities in the U.S. market, allowing for a broader reach and impact.
What kind of support do portfolio companies receive post-investment?
Portfolio companies benefit from industry expertise, access to a network of experts, and resources for commercialization, which are crucial for refining their offerings and achieving market success.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.